CIK 0001953926 · <br>Emerging growth company
Zenas BioPharma, Inc.
Sign in to watch- Ticker
- ZBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-271-2954
- Business address
- 852 WINTER STREET, SUITE 250, WALTHAM, MA, 02451
- Former names
- Zenas BioPharma (Cayman) Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-10 | Boylan James P Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2025-06-10 | Allen Patricia L Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2025-06-10 | Farmer Joseph L See Remarks | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2025-06-10 | Fairmount Funds Management LLC Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2025-06-10 | ENRIGHT PATRICK G Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2025-06-10 | ORLOFF JOHN J Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2025-06-10 | Lu Hongbo Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2025-06-10 | MOULDER LEON O JR See Remarks | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2025-06-10 | Nunn Jason Raleigh Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2025-04-15 | von Moltke Lisa See Remarks | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2025-02-18 | MOULDER LEON O JR Chief Executive Officer | Purchase | +25,000 | $6.67 | $167K | 266,155 |
| 2025-02-07 | Xiao Ting Director | Purchase | +10,000 | $7.76 | $78K | 10,000 |
| 2025-02-07 | Xiao Ting Director | Purchase | +10,000 | $7.76 | $78K | 47,000 |
| 2024-12-16 | Fox Jennifer A. See Remarks | Grant or award · Stock Option (Right to Buy) | +8,125 | 8,125 | ||
| 2024-12-16 | Oliveira Orlando Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +7,775 | 7,775 | ||
| 2024-12-04 | MOULDER LEON O JR Chief Executive Officer | Purchase | +45,000 | $9.98 | $449K | 241,155 |
| 2024-12-03 | MOULDER LEON O JR Chief Executive Officer | Purchase | +25,000 | $10.76 | $269K | 196,155 |
| 2024-11-19 | MOULDER LEON O JR Chief Executive Officer | Purchase | +2,500 | $14.57 | $36K | 171,155 |
| 2024-11-18 | MOULDER LEON O JR Chief Executive Officer | Purchase | +7,500 | $15.00 | $113K | 168,655 |
| 2024-09-20 | MOULDER LEON O JR Chief Executive Officer | Purchase | +2,367 | $17.88 | $42K | 1,669,406 |
Page 3 of 8 · 145 trades